Raymond James Financial Inc. Purchases New Shares in Establishment Labs Holdings Inc. (NASDAQ:ESTA)

Raymond James Financial Inc. acquired a new position in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 119,261 shares of the company's stock, valued at approximately $5,494,000. Raymond James Financial Inc. owned approximately 0.43% of Establishment Labs as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently bought and sold shares of ESTA. Federated Hermes Inc. grew its stake in Establishment Labs by 3.0% in the fourth quarter. Federated Hermes Inc. now owns 32,720 shares of the company's stock valued at $1,507,000 after purchasing an additional 953 shares in the last quarter. Sit Investment Associates Inc. raised its position in Establishment Labs by 104.7% during the fourth quarter. Sit Investment Associates Inc. now owns 21,600 shares of the company's stock valued at $995,000 after acquiring an additional 11,050 shares in the last quarter. Simplify Asset Management Inc. lifted its stake in Establishment Labs by 197.1% in the fourth quarter. Simplify Asset Management Inc. now owns 64,300 shares of the company's stock valued at $2,962,000 after acquiring an additional 42,661 shares during the last quarter. KLP Kapitalforvaltning AS bought a new stake in Establishment Labs in the fourth quarter worth approximately $161,000. Finally, Sei Investments Co. increased its stake in shares of Establishment Labs by 22.3% during the 4th quarter. Sei Investments Co. now owns 42,471 shares of the company's stock worth $1,957,000 after purchasing an additional 7,731 shares during the last quarter. 72.91% of the stock is owned by institutional investors and hedge funds.

Establishment Labs Stock Performance

ESTA stock traded up $0.09 on Wednesday, reaching $30.35. 214,259 shares of the company were exchanged, compared to its average volume of 459,087. The company has a debt-to-equity ratio of 5.94, a current ratio of 3.62 and a quick ratio of 2.29. Establishment Labs Holdings Inc. has a 12 month low of $26.56 and a 12 month high of $60.12. The stock's fifty day moving average price is $35.86 and its 200 day moving average price is $39.08. The firm has a market capitalization of $875.48 million, a PE ratio of -11.76 and a beta of 0.77.

Establishment Labs (NASDAQ:ESTA - Get Free Report) last issued its earnings results on Wednesday, February 26th. The company reported ($0.98) EPS for the quarter, missing the consensus estimate of ($0.64) by ($0.34). The firm had revenue of $44.51 million during the quarter, compared to the consensus estimate of $44.45 million. Establishment Labs had a negative return on equity of 184.55% and a negative net margin of 46.13%. On average, research analysts anticipate that Establishment Labs Holdings Inc. will post -2.41 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on the company. Stephens reaffirmed an "overweight" rating and issued a $52.00 price target on shares of Establishment Labs in a research report on Thursday, March 6th. Needham & Company LLC assumed coverage on Establishment Labs in a research report on Monday, April 14th. They set a "hold" rating for the company. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. According to data from MarketBeat, Establishment Labs currently has an average rating of "Moderate Buy" and a consensus target price of $57.40.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.